AU2002317910A1 - Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof - Google Patents

Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof

Info

Publication number
AU2002317910A1
AU2002317910A1 AU2002317910A AU2002317910A AU2002317910A1 AU 2002317910 A1 AU2002317910 A1 AU 2002317910A1 AU 2002317910 A AU2002317910 A AU 2002317910A AU 2002317910 A AU2002317910 A AU 2002317910A AU 2002317910 A1 AU2002317910 A1 AU 2002317910A1
Authority
AU
Australia
Prior art keywords
preparation
cyclic nucleotide
phosphodiesterase inhibitors
nucleotide phosphodiesterase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002317910A
Other versions
AU2002317910B2 (en
Inventor
Jean-Jacques Bourguignon
Eveline Klotz
Yan Lagouge
Claire Lugnier
Jean-Paul Macher
Pierre Raboisson
Dominique Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIA Pharmaceuticals Inc
Original Assignee
VIA Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIA Pharmaceuticals Inc filed Critical VIA Pharmaceuticals Inc
Priority claimed from PCT/FR2002/001952 external-priority patent/WO2002098865A2/en
Publication of AU2002317910A1 publication Critical patent/AU2002317910A1/en
Application granted granted Critical
Publication of AU2002317910B2 publication Critical patent/AU2002317910B2/en
Assigned to VIA PHARMACEUTICALS INC. reassignment VIA PHARMACEUTICALS INC. Request for Assignment Assignors: NEURO3D
Priority to AU2008221554A priority Critical patent/AU2008221554A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002317910A 2001-06-07 2002-06-07 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof Ceased AU2002317910B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008221554A AU2008221554A1 (en) 2001-06-07 2008-09-18 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/07458 2001-06-07
FR0107458 2001-06-07
PCT/FR2002/001952 WO2002098865A2 (en) 2001-06-07 2002-06-07 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008221554A Division AU2008221554A1 (en) 2001-06-07 2008-09-18 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof

Publications (2)

Publication Number Publication Date
AU2002317910A1 true AU2002317910A1 (en) 2003-05-08
AU2002317910B2 AU2002317910B2 (en) 2008-06-19

Family

ID=8864056

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002317910A Ceased AU2002317910B2 (en) 2001-06-07 2002-06-07 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
AU2008221554A Abandoned AU2008221554A1 (en) 2001-06-07 2008-09-18 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008221554A Abandoned AU2008221554A1 (en) 2001-06-07 2008-09-18 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof

Country Status (9)

Country Link
US (1) US7250410B2 (en)
EP (1) EP1392663A2 (en)
JP (1) JP2005503356A (en)
AU (2) AU2002317910B2 (en)
CA (1) CA2446696A1 (en)
IL (2) IL159105A0 (en)
NZ (1) NZ529582A (en)
WO (1) WO2002098865A2 (en)
ZA (1) ZA200400057B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572788B2 (en) * 1999-04-30 2009-08-11 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20030119029A1 (en) * 1999-04-30 2003-06-26 Regents Of The University Of Michigan Compositions and methods relating to novel benzodiazepine compounds and targets thereof
US20050113460A1 (en) * 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20060025388A1 (en) * 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
DE60007960T2 (en) 1999-04-30 2004-10-21 Univ Michigan Ann Arbor Therapeutic applications of pro-apoptotic benzodiazepines
CN1703395A (en) * 2002-08-09 2005-11-30 特兰斯泰克制药公司 Aryl and heteroaryl compounds and methods to modulate coagulation
AU2003288352A1 (en) * 2002-10-30 2004-06-07 Centre National De La Recherche Scientifique (Cnrs) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
FR2846653B1 (en) * 2002-10-30 2007-04-20 Neuro3D INHIBITORS OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, PREPARATION AND USES
US7459472B2 (en) * 2003-08-08 2008-12-02 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
EP1548011A1 (en) * 2003-12-23 2005-06-29 Neuro3D Benzo[1,4]diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
US20090275099A1 (en) * 2004-04-27 2009-11-05 Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
US20050272723A1 (en) * 2004-04-27 2005-12-08 The Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
FR2870539B1 (en) * 2004-05-19 2006-08-04 Greenpharma Sa Sa NEW METHODS AND MEDICINES
EP1784390A2 (en) 2004-08-13 2007-05-16 Amgen Inc. Substituted benzofused heterocycles
US20060052369A1 (en) * 2004-09-07 2006-03-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
EP1893218A4 (en) * 2005-06-01 2011-01-12 Univ Michigan Unsolvated benzodiazepine compositions and methods
US20070105844A1 (en) * 2005-10-26 2007-05-10 Regents Of The University Of Michigan Therapeutic compositions and methods
EP1948191B1 (en) * 2005-11-01 2013-01-16 The Regents of the University of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) * 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
EP2037741B1 (en) 2006-06-09 2013-11-27 The Regents Of The University Of Michigan Benzodiazepine derivatives for use in the treatment of immune, inflammatory and proliferative disorders
CA2680017C (en) 2007-03-09 2013-11-12 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
CA2685860A1 (en) * 2007-05-10 2008-11-20 Amr Technology, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CA2698248C (en) * 2007-09-14 2017-08-29 The Regents Of The University Of Michigan Phenyl acyl guanidine derivatives as f1f0-atpase inhibitors and the use thereof
WO2009037302A1 (en) * 2007-09-18 2009-03-26 Via Pharmaceuticals, Inc. 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors
CA2703005A1 (en) 2007-11-06 2009-05-14 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
US8497307B2 (en) 2008-09-11 2013-07-30 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
EP2470020A4 (en) 2009-09-18 2013-03-13 Univ Michigan Benzodiazepinone compounds and methods of treatment using same
CA2780333C (en) 2009-11-17 2016-05-24 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
AU2010322287B2 (en) 2009-11-17 2014-04-03 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
AR084070A1 (en) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc BROMODOMINIUM INHIBITORS AND USES OF THE SAME
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (en) 2012-06-06 2017-10-21 星宿藥物公司 Bromodomain inhibitors and uses thereof
CA2952830C (en) 2014-06-20 2022-11-01 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
WO2023220395A1 (en) * 2022-05-13 2023-11-16 University Of Cincinnati Benzodiazepine analogs and methods of use in treating cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH414652A (en) 1959-12-10 1966-06-15 Hoffmann La Roche Process for the preparation of 1,4-benzodiazepine derivatives
NL279830A (en) 1961-06-20
US3182067A (en) 1964-04-09 1965-05-04 Hoffmann La Roche Benzodiazepine compounds
FR1497456A (en) 1964-06-15 1967-10-13 Clin Byla Ets Ortho-amino aryl ketimines, heterocyclic compounds attached to them and preparation of these various bodies
IL29988A0 (en) 1967-06-23 1968-07-25 American Cyanamid Co Novel 7-trifluoromethoxybenzo-1,4-diazepines
US3631029A (en) 1967-12-01 1971-12-28 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
FR2085645A1 (en) 1970-04-22 1971-12-31 Chimidrog 1-phenyl-2,3-benzodiazepin-4-ones - as tranquillizers
US3801569A (en) 1973-01-15 1974-04-02 Hoffmann La Roche 7-(1,1-difluoroalkyl)-1,4-benzodiazepines
DE3119874A1 (en) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "BENZAZEPINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS"
PH26955A (en) 1989-03-08 1992-12-03 Kali Chemie Pharma Gmbh Novel 1,7-fused 1H-indole-2-carboxylic acid N-(1,4-benzodiazepin-3-YL) amides
TW221687B (en) 1992-01-24 1994-03-11 Hoffmann La Roche
DE19604920A1 (en) * 1996-02-01 1997-08-07 Schering Ag New 2,3-benzodiazepine derivatives, their production and use as medicines
US5891871A (en) 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
AU4565600A (en) 1999-06-18 2001-01-09 Synt:Em (S.A.) Identifying active molecules using physico-chemical parameters
WO2002051232A2 (en) 2000-12-27 2002-07-04 Actelion Pharmaceuticals Ltd. Novel benzazepines and related heterocyclic derivatives

Similar Documents

Publication Publication Date Title
AU2002317910A1 (en) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
IL159105A0 (en) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
AU2002362895A1 (en) 5-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
AU2002312933A1 (en) CDK inhibiting pyrimidines, production thereof and their use as medicaments
AU2002346929A1 (en) 5-acylamino-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
AU2002359126A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2003301066A1 (en) Al2o3-la2o3-y2o3-mgo ceramics, and methods of making the same
AU2002359123A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002239571A1 (en) Kinases and phosphatases sequences, and use thereof
AU2002335439A1 (en) Clip
AU2001282746A1 (en) Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
AU2001100139A4 (en) Yoga headstander
AU2002350599A1 (en) Homeotic genes and proteins, and uses thereof
AUPR282501A0 (en) Expression facilitating nucleotides
AU2002257892A1 (en) Compounds inhibiting cyclic nucleotide phosphodiesterases, preparation and uses thereof
AU2002330205A1 (en) Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof
AU2002234835A1 (en) Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
AU2002253038A1 (en) Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
AU2003289640A1 (en) Tricyclacetalactonin, Preparation and Use there of
AU2002317850A1 (en) 1-alkyl 0r 1-cycloalkyltriazolo(4,3-a)quinazolin-5-ones as phosphodiesterase inhibitors
AU2002250749A1 (en) Antisense calpain nucleotides and uses thereof
AU2002251139A1 (en) Polypeptides derived from rna polymerases and use thereof
AUPR689401A0 (en) Improved clip